Lacroix L - Search Results

1

Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non-Small-Cell Lung Cancer.

Remon J, Lacroix L, Jovelet C, Caramella C, Howarth K, Plagnol V, Rosenfeld N, Morris C, Mezquita L, Pannet C, Ngocamus M, Le Pechoux C, Adam J, Grecea AM, Planchard D, Vassal G, Benitez JC, Gazzah A, Green E, Soria JC, Besse B. Remon J, et al. Among authors: lacroix l. JCO Precis Oncol. 2019 Mar 6;3:PO.18.00211. doi: 10.1200/PO.18.00211. eCollection 2019. JCO Precis Oncol. 2019. PMID: 32914037 Free PMC article.

2

Gene expression profiling of non-small-cell lung cancer.

Lacroix L, Commo F, Soria JC. Lacroix L, et al. Expert Rev Mol Diagn. 2008 Mar;8(2):167-78. doi: 10.1586/14737159.8.2.167. Expert Rev Mol Diagn. 2008. PMID: 18366303 Review.

3

Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.

André F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, Vielh P, Delaloge S. André F, et al. Among authors: lacroix l. Lancet Oncol. 2009 Apr;10(4):381-90. doi: 10.1016/S1470-2045(09)70024-5. Epub 2009 Feb 25. Lancet Oncol. 2009. PMID: 19249242

4

Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.

Peyre M, Commo F, Dantas-Barbosa C, Andreiuolo F, Puget S, Lacroix L, Drusch F, Scott V, Varlet P, Mauguen A, Dessen P, Lazar V, Vassal G, Grill J. Peyre M, et al. Among authors: lacroix l. PLoS One. 2010 Sep 24;5(9):e12932. doi: 10.1371/journal.pone.0012932. PLoS One. 2010. PMID: 20885975 Free PMC article.

5

Implications of personalized medicine--perspective from a cancer center.

Tursz T, Andre F, Lazar V, Lacroix L, Soria JC. Tursz T, et al. Among authors: lacroix l. Nat Rev Clin Oncol. 2011 Mar;8(3):177-83. doi: 10.1038/nrclinonc.2010.222. Nat Rev Clin Oncol. 2011. PMID: 21364691 Review.

6

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3.

Borget I, Cadranel J, Pignon JP, Quoix E, Coudert B, Westeel V, Dansin E, Madelaine J, Madroszyk A, Friard S, Daniel C, Morin F, Chouaid C; ERMETIC Collaborative Group. Borget I, et al. Eur Respir J. 2012 Jan;39(1):172-9. doi: 10.1183/09031936.00201210. Epub 2011 Jun 9. Eur Respir J. 2012. PMID: 21659409 Free article.

7

Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.

Friboulet L, Barrios-Gonzales D, Commo F, Olaussen KA, Vagner S, Adam J, Goubar A, Dorvault N, Lazar V, Job B, Besse B, Validire P, Girard P, Lacroix L, Hasmats J, Dufour F, André F, Soria JC. Friboulet L, et al. Among authors: lacroix l. Clin Cancer Res. 2011 Sep 1;17(17):5562-72. doi: 10.1158/1078-0432.CCR-11-0790. Epub 2011 Jul 12. Clin Cancer Res. 2011. PMID: 21750204

8

Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.

Arnault JP, Mateus C, Escudier B, Tomasic G, Wechsler J, Hollville E, Soria JC, Malka D, Sarasin A, Larcher M, André J, Kamsu-Kom N, Boussemart L, Lacroix L, Spatz A, Eggermont AM, Druillennec S, Vagner S, Eychène A, Dumaz N, Robert C. Arnault JP, et al. Among authors: lacroix l. Clin Cancer Res. 2012 Jan 1;18(1):263-72. doi: 10.1158/1078-0432.CCR-11-1344. Epub 2011 Nov 17. Clin Cancer Res. 2012. PMID: 22096025

9

The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: the case of the Institut Gustave Roussy.

Arnedos M, André F, Farace F, Lacroix L, Besse B, Robert C, Soria JC, Eggermont AM. Arnedos M, et al. Among authors: lacroix l. Mol Oncol. 2012 Apr;6(2):204-10. doi: 10.1016/j.molonc.2012.02.008. Epub 2012 Mar 16. Mol Oncol. 2012. PMID: 22483534 Free PMC article. Review.

10

Molecular guided therapy for advanced pancreatic cancer patients with PI3K activated mutation: vision or illusion?

Gazzah A, Gonzales DB, Levy A, Bahleda R, Ducreux M, Lacroix L, Soria JC. Gazzah A, et al. Among authors: lacroix l. Onco Targets Ther. 2013;6:95-7. doi: 10.2147/OTT.S38520. Epub 2013 Feb 20. Onco Targets Ther. 2013. PMID: 23450148 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

503 results

Search Page